Resources

Welcome to our searchable resource and literature collection on safer supply and related topics.

Found a broken link? Links do move around, so if you find one here that's broken, please let us know through the Contact form.

 

Assessing the determinants of completing OAT induction and long-term retention: A population-based study in British Columbia, Canada

Induction into opioid agonist treatment (OAT) features the highest risk of mortality throughout the treatment course, and greatest risk of discontinuation.
Original research | 2021
Evidence base, Advocacy, Outcomes, Substitution/OAT, Transitions in care/treatment

Buprenorphine-naloxone microdosing: Tool for opioid agonist therapy induction

To raise awareness of alternative techniques that can facilitate buprenorphine-naloxone treatment for opioid use disorder.
Original research | 2020
Clinical guidance, Harm reduction, About prescribers, Substitution/OAT

Comparison of Characteristics of Deaths From Drug Overdose Before vs During the COVID-19 Pandemic in Rhode Island

Were there changes in the rate and characteristics of deaths from drug overdose before vs during the COVID-19 pandemic in Rhode Island?
Original research | 2021
Overdose, Mortality, Housing, Illegal drugs, Sex/Gender , Mental health

COVID-19 and overdose prevention: Challenges and opportunities for clinical practice in housing settings

Commentary | 2020
Harm reduction, Safer supply, Housing, Illegal drugs

Development and assessment of a community-based screening tool for mental health disorders among people who inject drugs

The objectives of this study were to design and assess a quick screening tool (QST) that community-based organisations (CBO) could routinely apply to a Vietnamese population of people who inject drugs
Original research | 2021
Wrap-around services, About PWUD, Social services, Illegal drugs, Peer/PWLLE program involvement, Mental health

Drug Checking Services for People Who Use Drugs: A Systematic Review

We sought to identify and synthesize literature on the following domains: (a) influence of drug checking services on behaviour of people who use drugs; (b) monitoring of drug markets by drug checking
Lit review | 2021
Harm reduction, About PWUD, Barriers and enablers, Illegal drugs, Drug checking

Evaluation of 6 remote First Nations community-based buprenorphine programs in northwestern Ontario

To evaluate established opioid addiction treatment programs that use traditional healing in combination with buprenorphine-naloxone maintenance treatment in 6 First Nations communities in the Sioux Lo
Original research | 2017
Evidence base, Policy/Regulatory, Wrap-around services, Safer supply, About prescribers, Social services, Outcomes, Indigenous, Rural/remote, Substitution/OAT

Expanding access to diacetylmorphine and hydromorphone for people who use opioids in Canada

This commentary explores the current state of policy and practice for diacetylmorphine and hydromorphone as opioid substitution options in Canada, outlines the rationale for rapid expansion of access,
Commentary | 2020
Policy/Regulatory, Advocacy

Feasibility and acceptability of a digital health intervention to promote engagement in and adherence to medication for opioid use disorder

The goal of this study was to elucidate key elements surrounding the acceptability/feasibility and structure of an interactive computer- and text message–delivered personalized feedback intervention f
Original research | 2021
About PWUD, Substitution/OAT, Digital health

Opioid agonist treatment and patient outcomes during the COVID-19 pandemic in south east Sydney, Australia

Describes Covid-related changed to treatment & preliminary analysis of the association with patients' substance use and well-being.
Original research | 2021
Evidence base, Harm reduction, Safer supply, Advocacy, About prescribers, Outcomes

Opioid agonist treatment uptake within provincial correctional facilities in British Columbia, Canada

We aimed to estimate the impact of policy changes and the announcement of the opioid overdose-related public health emergency on the use of OAT for incarcerated individuals with opioid use disorder.
Original research | 2021
Policy/Regulatory, Legal system/law enforcement, Substitution/OAT

Perspectives of people who use opioids and prescribers on opioid agonist therapy during the pandemic: Findings from the ALT-POP Study

Evaluate the rapid transformation of pandemic-related OAT prescribing patterns from the perspective of people who use opioids and prescribers, including both positive and negative effects.

Slide deck | 2021
Harm reduction, About prescribers, About PWUD, Barriers and enablers, Substitution/OAT, Digital health, Diversion, Carries/take-home doses

Third party drug checking: accessing harm reduction services on the behalf of others

We aim to examine the frequency of third party use of a community drug checking service to explore the potential for harm reduction to extend beyond the individual into the community, increase service
Original research | 2021
Harm reduction, Illegal drugs, Drug checking, Social benefits

Treatment options and shared decision-making in the treatment of opioid use disorder: A scoping review

Shared decision-making (SDM) is an approach to clinical decision-making that includes patients' values and preferences during health-related decisions.
Scoping review | 2021
Clinical guidance, About prescribers, About PWUD

Unsafe Supply: Why Making Controlled Prescription Drugs Available for Unsupervised Use Will Not Target the Syndemic of HIV, Hepatitis C, Overdose, and COVID-19— A Commentary on Bonn et al. (2020)

Commentary on Bonn et all 2020
Commentary | 2020
Safer supply

Using intervention mapping to develop ‘ROSE’: an intervention to support peer workers in overdose response settings

Peer workers (those with lived/living experience of substance use working in overdose response settings) are at the forefront of overdose response initiatives in British Columbia (BC).
Original research | 2021
Harm reduction, Peer/PWLLE program involvement

Which lives are worth saving? Biolegitimacy and harm reduction during COVID-19

This article draws on the theoretical work of Foucault and scholars who further developed his concept of biopolitics.
Commentary | 2021
Safer supply, Decriminalization/legalization, Equity, Advocacy, Housing

“They’re not doing enough.”: women’s experiences with opioids and naloxone in Toronto

Study women's experiences and perspectives on the opioid crisis
Original research | 2021
About PWUD, Legal system/law enforcement, Sex/Gender , Stigma

'It's too much, I'm getting really tired of it': Overdose response and structural vulnerabilities among harm reduction workers in community settings

This study examines structural vulnerabilities that constrain PWUD as they attempt to implement overdose education and naloxone distribution program advice.
Original research | 2019
Overdose, Harm reduction, Policy/Regulatory, Safer supply, Decriminalization/legalization, Advocacy, About PWUD, Barriers and enablers, Illegal drugs, Peer/PWLLE program involvement, Sex/Gender , SCS/OPS

Association between fatal opioid overdose and state medical cannabis laws in US national survey data, 2000-2011

Assess whether state medical cannabis laws were associated with reduced risk of fatal opioid overdose between 2000-2011.
Original research | 2022
Mortality, Policy/Regulatory, Barriers and enablers, Illegal drugs

Refine Your Search

Keywords
Format
Region